RVTY (Revvity) Cyclically Adjusted Revenue per Share: $0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RVTY Revvity Inc RVTY
78 GF Score
Price $114.66
GF Value $117.91
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Revvity Cyclically Adjusted Revenue per Share?

Revvity RVTY +0.37% 78 Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2026. GuruFocus rates RVTY with a GF Score™ of 78/100 and a GF Value™ of $117.91 (Fairly Valued). The stock has 11 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Revvity's adjusted revenue per share for the three months ended in Jun. 2026 was $6.537. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Revvity's average Cyclically Adjusted Revenue Growth Rate was 3.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Revvity was 9.00% per year. The lowest was -8.20% per year. And the median was 2.10% per year.

As of today (2026-08-08), Revvity's current stock price is $114.66. Revvity's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $0.00. Revvity's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Revvity was 7.91. The lowest was 2.77. And the median was 4.16.


Revvity  (NYSE:RVTY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Revvity was 7.91. The lowest was 2.77. And the median was 4.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Revvity Cyclically Adjusted Revenue per Share Related Terms


Revvity Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Revvity's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity Cyclically Adjusted Revenue per Share Chart

Revvity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.41 27.32 27.95 28.59 29.28

Revvity Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.08 29.21 29.28 29.85 0.00

RVTY vs ICLR, CRL, QGEN: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Revvity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Revvity's Cyclically Adjusted PS Ratio falls into.


RVTY
78GF Score
Revvity Inc RVTY
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revvity Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Revvity's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.537/333.9520*333.9520
=6.537

Current CPI (Jun. 2026) = 333.9520.

Revvity Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 4.674 241.428 6.465
201612 5.146 241.432 7.118
201703 4.665 243.801 6.390
201706 4.938 244.955 6.732
201709 4.994 246.819 6.757
201712 5.756 246.524 7.797
201803 5.784 249.554 7.740
201806 6.311 251.989 8.364
201809 6.034 252.439 7.982
201812 6.777 251.233 9.008
201903 5.829 254.202 7.658
201906 6.478 256.143 8.446
201909 6.337 256.759 8.242
201912 7.216 256.974 9.378
202003 5.844 258.115 7.561
202006 7.256 257.797 9.399
202009 8.585 260.280 11.015
202012 2.089 260.474 2.678
202103 11.624 264.877 14.655
202106 10.928 271.696 13.432
202109 7.488 274.310 9.116
202112 8.108 278.802 9.712
202203 7.606 287.504 8.835
202206 7.080 296.311 7.979
202209 5.625 296.808 6.329
202212 5.873 296.797 6.608
202303 5.336 301.836 5.904
202306 5.655 305.109 6.190
202309 5.400 307.789 5.859
202312 5.642 306.746 6.142
202403 5.261 312.332 5.625
202406 5.602 314.175 5.955
202409 5.560 315.301 5.889
202412 6.007 315.605 6.356
202503 5.529 319.799 5.774
202506 6.128 322.561 6.344
202509 6.053 324.800 6.224
202512 6.822 324.054 7.030
202603 6.356 330.213 6.428
202606 6.537 333.952 6.537

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
Revvity (RVTY) has a Cyclically Adjusted Revenue per Share of $0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Revvity and its competitors.
Is Revvity's Cyclically Adjusted Revenue per Share too high?
Revvity's current Cyclically Adjusted Revenue per Share is $0.00. Overall, Revvity has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Revvity's Cyclically Adjusted Revenue per Share compare to ICLR and CRL?
Revvity's Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Revvity and its competitors. Revvity's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Based on GuruFocus' analysis, Revvity (RVTY) is currently considered Fairly Valued. The stock's GF Value™ is $117.91, compared to a current price of $114.66 — trading 2.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.00. Revvity's overall GF Score™ is 78/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Revvity (RVTY), the current Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (RVTY) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of $114.66 is trading 2.8% below its estimated GF Value™ of $117.91. GuruFocus considers Revvity to be Fairly Valued.

Key valuation signals for RVTY:

  • Cyclically Adjusted Revenue per Share: $0.00
  • GF Value™: $117.91 vs. price of $114.66 (2.8% below fair value)
  • GF Score™: 78/100 with 11 warning signs

No single metric tells the full story. See the RVTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
78GF Score

Get the complete analysis for RVTY

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$114.66
Price
$117.91
GF Value